Invesco
NBP

Invesco’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Invesco’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.3K Buy
28,161
+7,758
+38% +$26K ﹤0.01% 3665
2025
Q4 		$81.2K Buy
+20,403
New +$90.3K ﹤0.01% 3658
2024
Q3 		– Sell
-57,933
Closed -$96.7K – 3811
2024
Q2 		$96.7K Sell
57,933
-27,211
-32% -$48.6K ﹤0.01% 3757
2024
Q1 		$158K Buy
85,144
+65,381
+331% +$120K ﹤0.01% 3690
2023
Q4 		$37.5K Sell
19,763
-64,399
-77% -$96.2K ﹤0.01% 3773
2023
Q3 		$111K Buy
84,162
+9,225
+12% +$20.3K ﹤0.01% 3703
2023
Q2 		$224K Sell
74,937
-12,085
-14% -$38.8K ﹤0.01% 3582
2023
Q1 		$301K Buy
87,022
+12,077
+16% +$58.5K ﹤0.01% 3501
2022
Q4 		$313K Buy
74,945
+117
+0.2% +$443 ﹤0.01% 3494
2022
Q3 		$300K Sell
74,828
-2
-0% -$15 ﹤0.01% 3512
2022
Q2 		$846K Buy
74,830
+7,219
+11% +$86.5K ﹤0.01% 3061
2022
Q1 		$1.1M Buy
67,611
+25,829
+62% +$662K ﹤0.01% 3030
2021
Q4 		$1.98M Buy
41,782
+6,342
+18% +$381K ﹤0.01% 2799
2021
Q3 		$2.57M Buy
35,440
+11,486
+48% +$831K ﹤0.01% 2700
2021
Q2 		$2.01M Buy
23,954
+7,981
+50% +$527K ﹤0.01% 2839
2021
Q1 		$774K Buy
15,973
+2,376
+17% +$129K ﹤0.01% 3155
2020
Q4 		$641K Buy
13,597
+6,365
+88% +$251K ﹤0.01% 3115
2020
Q3 		$340K Buy
7,232
+54
+0.8% +$1.78K ﹤0.01% 3273
2020
Q2 		$215K Buy
+7,178
New +$148K ﹤0.01% 3456

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
AIHC Capital Management Central $120M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco's NBP Position: Q1 2026 in Review

Invesco increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 38% in Q1 2026, buying an estimated $26K and bringing the position to 28,161 shares worth $69.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3665.

Invesco first reported a position in NBP in Q2 2020 and has held it in 19 quarters since. The position peaked at $2.57M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Invesco held 28,161 shares of NovaBridge Biosciences American Depositary Shares worth $69.3K as of Q1 2026.
  • Invesco bought 7,758 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $26K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3665 holding.
  • Invesco first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and has held it in 19 quarters since.
  • Invesco's NovaBridge Biosciences American Depositary Shares position peaked at $2.57M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.